Abstract
Rhabdomyosarcoma is a relatively common soft tissue sarcoma that frequently affects children and adolescents and may involve the head and neck. Rhabdomyosarcoma is defined by skeletal muscle differentiation which can be suggested by routine histology and confirmed by immunohistochemistry for the skeletal muscle-specific markers myogenin or myoD1. At the same time, it must be remembered that when it comes to head and neck malignancies, skeletal muscle differentiation is not limited to rhabdomyosarcoma. A lack of awareness of this phenomenon could lead to misdiagnosis and, subsequently, inappropriate therapeutic interventions. This review focuses on malignant neoplasms of the head and neck other than rhabdomyosarcoma that may exhibit rhabdomyoblastic differentiation, with an emphasis on strategies to resolve the diagnostic dilemmas these tumors may present. Axiomatically, no primary central nervous system tumors will be discussed.
Similar content being viewed by others
References
Scrable HJ, Witte DP, Lampkin BC, et al. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature. 1987;329:645–7.
Bridge JA, Liu J, Qualman SJ, et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer. 2002;33:310–21.
Barr FG. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene. 2001;20:5736–46.
Barr FG, Galili N, Holick J, et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993;3:113–7.
Miettinen M, Fetsch JF, Antonescu CR, et al. Tumors with skeletal muscle differentiation. AFIP atlas of tumor pathology: tumors of the soft tissues. Silver Spring: ARP Press; 2014. p. 289–308.
Kohsaka S, Shukla N, Ameur N, et al. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3 K-AKT pathway mutations. Nat Genet. 2014;46:595–600.
Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013;20:387–97.
Barr FG. New treatments for rhabdomyosarcoma: the importance of target practice. Clin Cancer Res. 2012;18:595–7.
Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol. 1995;13:610–30.
Hicks J, Flaitz C. Rhabdomyosarcoma of the head and neck in children. Oral Oncol. 2002;38:450–9.
Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 1995;13:2123–39.
Nayar RC, Prudhomme F, Parise O Jr, et al. Rhabdomyosarcoma of the head and neck in adults: a study of 26 patients. Laryngoscope. 1993;103:1362–6.
Feldman BA. Rhabdomyosarcoma of the head and neck. Laryngoscope. 1982;92:424–40.
Wiener ES. Head and neck rhabdomyosarcoma. Semin Pediatr Surg. 1994;3:203–6.
Morotti RA, Nicol KK, Parham DM, et al. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children’s Oncology Group experience. Am J Surg Pathol. 2006;30:962–8.
Walterhouse D, Watson A. Optimal management strategies for rhabdomyosarcoma in children. Paediatr Drugs. 2007;9:391–400.
Antonescu CR, Scheithauer BW, Woodruff JM. Malignant tumors of peripheral nerves. AFIP atlas of tumor pathology: tumors of the peripheral nervous system. Silver Spring: ARP Press; 2013. p. 381–474.
Lewis JJ, Brennan MF. Soft tissue sarcomas. Curr Probl Surg. 1996;33:817–72.
Reid RJ. The neural crest, its migrants, and cutaneous malignant neoplasms related to neurocristic derivatives. In: Lynch HT, Fusaro RM, editors. Cancer associated genodermatoses. New York: Nan Nostrand Reinhold; 1982. p. 171–222.
Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest. 1983;49:299–308.
Bahrami A, Gown AM, Baird GS, et al. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21:795–806.
Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Semin Diagn Pathol. 1994;11:69–81.
Woodruff JM, Chernik NL, Smith MC, et al. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant “Triton” tumors). Cancer. 1973;32:426–39.
Masson P. Recklinghausen’s neurofibromatosis, sensory neuromas and motor neuromas. Contributions to the Medical Sciences in Honor of Dr Emanuel Libman by his Pupils, Friends and Colleagues. New York: International Press; 1932:793–802.
Pytel P, Taxy JB, Krausz T. Divergent differentiation in malignant soft tissue neoplasms: the paradigm of liposarcoma and malignant peripheral nerve sheath tumor. Int J Surg Pathol. 2005;13:19–28.
Tiffee JC, Barnes EL. Neuromuscular hamartomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:212–6.
Sorensen KB, Godballe C, Krogdahl A. Malignant triton tumor (MTT) of the neck. Auris Nasus Larynx. 2006;33:89–91.
Bhatt S, Graeme-Cook F, Joseph MP, et al. Malignant triton tumor of the head and neck. Otolaryngol Head Neck Surg. 1991;105:738–42.
Victoria L, McCulloch TM, Callaghan EJ, et al. Malignant triton tumor of the head and neck: a case report and review of the literature. Head Neck. 1999;21:663–70.
Kamran SC, Howard SA, Shinagare AB, et al. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol. 2013;39:46–52.
McConnell YJ, Giacomantonio CA. Malignant triton tumors-complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol. 2012;106:51–6.
James JA, Bali NS, Sloan P, et al. Low-grade malignant Triton tumor of the oral cavity: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:699–704.
Omar T, Raslan H, El Sheikh S, et al. Low-grade malignant triton tumor of the neck: a case report and review of the literature. Case Rep Pathol. 2014;2014:674094.
Terzic A, Bode B, Gratz KW, et al. Prognostic factors for the malignant triton tumor of the head and neck. Head Neck. 2009;31:679–88.
Lewis JT, Oliveira AM, Nascimento AG, et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–25.
Coindre JM, de Mascarel A, Trojani M, et al. Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin. J Pathol. 1988;155:127–32.
Nappi O, Wick MR. Sarcomatoid neoplasms of the respiratory tract. Semin Diagn Pathol. 1993;10:137–47.
Batsakis JG, Suarez P. Sarcomatoid carcinomas of the upper aerodigestive tracts. Adv Anat Pathol. 2000;7:282–93.
Cardesa A, Zidar N. Spindle cell carcinoma. In: Barnes L, Eveson JW, Reichart P, et al., editors. World Health Organization classification of tumours pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005. p. 127–8.
Thompson LD, Wieneke JA, Miettinen M, et al. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol. 2002;26:153–70.
Lane N. Pseudosarcoma (polypoid sarcoma-like masses) associated with squamous-cell carcinoma of the mouth, fauces, and larynx. Cancer. 1957;10:19.
Ansari-Lari MA, Hoque MO, Califano J, et al. Immunohistochemical p53 expression patterns in sarcomatoid carcinomas of the upper respiratory tract. Am J Surg Pathol. 2002;26:1024–31.
Kojc N, Zidar N, Gale N, et al. Transcription factors snail, slug, twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2009;454:549–55.
Zidar N, Bostjancic E, Gale N, et al. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck-hallmark of epithelial-mesenchymal transition. Hum Pathol. 2011;42:482–8.
Zidar N, Gale N, Kojc N, et al. Cadherin–catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2008;453:267–74.
Zarbo RJ, Crissman JD, Venkat H, et al. Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors. Am J Surg Pathol. 1986;10:741–53.
Lewis JE, Olsen KD, Sebo TJ. Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol. 1997;28:664–73.
Batsakis JG, Rice DH, Howard DR. The pathology of head and neck tumors: spindle cell lesions (sarcomatoid carcinomas, nodular fasciitis, and fibrosarcoma) of the aerodigestive tracts, Part 14. Head Neck Surg. 1982;4:499–513.
Ellis GL, Corio RL. Spindle cell carcinoma of the oral cavity. A clinicopathologic assessment of fifty-nine cases. Oral Surg Oral Med Oral Pathol. 1980;50:523–33.
Batsakis JG, Suarez P. Sarcomatoid carcinomas of the upper aerodigestive tracts. Adv Anatomic Pathol. 2000;7:282–93.
Roy S, Purgina B, Seethala RR. Spindle cell carcinoma of the larynx with rhabdomyoblastic heterologous element: a rare form of divergent differentiation. Head Neck Pathol. 2013;7:263–7.
Goldman RL, Weidner N. Pure squamous cell carcinoma of the larynx with cervical nodal metastasis showing rhabdomyosarcomatous differentiation. Clinical, pathologic, and immunohistochemical study of a unique example of divergent differentiation. Am J Surg Pathol. 1993;17:415–21.
Srinivasan U, Talvalkar GV. True carcinosarcoma of the larynx: a case report. J Laryngol Otol. 1979;93:1031–5.
Ferlito A. Surgical pathology of laryngeal neoplasms. London: Chapman & Hall Medical; 1996.
Doglioni C, Ferlito A, Chiamenti C, et al. Laryngeal carcinoma showing multidirectional epithelial neuroendocrine and sarcomatous differentiation. ORL J Otorhinolaryngol Relat Spec. 1990;52:316–26.
Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014;38:257–64.
Jo VY, Fletcher CD. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol. 2011;136:762–6.
Lewis JS, Ritter JH, El-Mofty S. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol. 2005;18:1471–81.
Rosai J, DeLellis RA, Carcangiu ML, et al. Undifferentiated (anaplastic) thyroid carcinoma. AFIP atlas of tumor pathology: tumors of the thyroid and parathyroid glands. Silver Spring: ARP Press; 2014. p. 177–98.
Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, et al. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions. Am J Surg Pathol. 2007;31:729–36.
Carda C, Ferrer J, Vilanova M, et al. Anaplastic carcinoma of the thyroid with rhabdomyosarcomatous differentiation: a report of two cases. Virchows Arch. 2005;446:46–51.
Bishop JA, Sharma R, Westra WH. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol. 2011;42:1873–7.
Nonaka D, Tang Y, Chiriboga L, et al. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 2008;21:192–200.
Dutta M, Chatterjee I, Roy S, et al. Primary embryonal rhabdomyosarcoma of the anterior neck and thyroid: report of a new case with review of the literature. Laryngoscope. 2013;123:2072–6.
Furze AD, Lehman DA, Roy S. Rhabdomyosarcoma presenting as an anterior neck mass and possible thyroid malignancy in a seven-month-old. Int J Pediatr Otorhinolaryngol. 2005;69:267–70.
Begum S, Rosenbaum E, Henrique R, et al. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment. Mod Pathol. 2004;17:1359–63.
Takano T, Ito Y, Hirokawa M, et al. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. Br J Cancer. 2007;96:1549–53.
Ellis GL, Auclair PL. Tumors of the salivary glands. Washington, D.C.: ARP Press; 2008.
Ellis GL, Auclair PL. Carcinoma ex pleomorphic adenoma. AFIP atlas of tumor pathology: tumors of the salivary glands. Washington, D.C.: ARP Press; 2008.
Ellis GL, Auclair PL. Carcinosarcoma. AFIP atlas of tumor pathology: tumors of the salivary glands. Washington, D.C.: ARP Press; 2008. p. 363–8.
Ueo T, Kaku N, Kashima K, et al. Carcinosarcoma of the parotid gland: an unusual case with large-cell neuroendocrine carcinoma and rhabdomyosarcoma—Case report. Apmis. 2005;113:456–64.
Gandour-Edwards RF, Donald PJ, Vogt PJ, et al. Carcinosarcoma (malignant mixed tumor) of the parotid: report of a case with a pure rhabdomyosarcoma component. Head Neck. 1994;16:379–82.
Tanahashi J, Daa T, Kashima K, et al. Carcinosarcoma ex recurrent pleomorphic adenoma of the submandibular gland—Case report. Apmis. 2007;115:789–94.
Kwon MY, Gu M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: a case report and review of the literature. Arch Pathol Lab Med. 2001;125:812–5.
Yura S, Terahata S, Ohga N, et al. A case of carcinosarcoma arising in the submandibular gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2007;103:820–4.
Wenig BM, Dulguerov P, Kapadia SB, et al. Neuroectodermal tumours. In: Barnes L, Eveson JW, Reichart P, et al., editors. World Health Organization classification of tumours pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005. p. 65–75.
Thompson LD. Olfactory neuroblastoma. Head Neck Pathol. 2009;3:252–9.
Frierson HF Jr, Ross GW, Mills SE, et al. Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol. 1990;94:547–53.
Miller DC, Goodman ML, Pilch BZ, et al. Mixed olfactory neuroblastoma and carcinoma. A report of two cases. Cancer. 1984;54:2019–28.
Sugita Y, Kusano K, Tokunaga O, et al. Olfactory neuroepithelioma: an immunohistochemical and ultrastructural study. Neuropathology. 2006;26:400–8.
Curtis JL, Rubinstein LJ. Pigmented olfactory neuroblastoma: a new example of melanotic neuroepithelial neoplasm. Cancer. 1982;49:2136–43.
Miyagami M, Katayama Y, Kinukawa N, et al. An ultrastructural and immunohistochemical study of olfactory neuroepithelioma with rhabdomyoblasts. Med Electron Microsc. 2002;35:160–6.
Slootweg PJ, Lubsen H. Rhabdomyoblasts in olfactory neuroblastoma. Histopathology. 1991;19:182–4.
Dias P, Chen B, Dilday B, et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol. 2000;156:399–408.
Bockmuhl U, You X, Pacyna-Gengelbach M, et al. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol. 2004;14:158–63.
Heffner DK, Hyams VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses A clinicopathologic study of 20 cases. Cancer. 1984;53:2140–54.
Cardesa A, Luna MA. Germ cell tumors. In: Barnes L, Eveson JW, Reichart P, et al., editors. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 76–9.
Smith SL, Hessel AC, Luna MA, et al. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch Otolaryngol Head Neck Surg. 2008;134:592–5.
Fernandez PL, Cardesa A, Alos L, et al. Sinonasal teratocarcinosarcoma: an unusual neoplasm. Pathol Res Pract. 1995;191:166–71 discussion 172–163.
Misra P, Husain Q, Svider PF, et al. Management of sinonasal teratocarcinosarcoma: a systematic review. Am J Otolaryngol. 2014;35:5–11.
Yang S, Sun R, Liang J, et al. Sinonasal teratocarcinosarcoma: a clinical and pathological analysis. Int J Surg Pathol. 2013;21:37–43.
Budrukkar A, Agarwal JP, Kane S, et al. Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. J Laryngol Otol. 2010;124:739–43.
Batsakis JG, el-Naggar AK, Luna MA. Teratomas of the head and neck with emphasis on malignancy. Ann Otol Rhinol Laryngol. 1995;104:496–500.
Colton JJ, Batsakis JG, Work WP. Teratomas of the neck in adults. Arch Otolaryngol. 1978;104:271–2.
Thompson LD, Rosai J, Heffess CS. Primary thyroid teratomas: a clinicopathologic study of 30 cases. Cancer. 2000;88:1149–58.
Vujanic GM, Harach HR, Minic P, et al. Thyroid/cervical teratomas in children: immunohistochemical studies for specific thyroid epithelial cell markers. Pediatr Pathol. 1994;14:369–75.
Banerjee SS, Eyden B. Divergent differentiation in malignant melanomas: a review. Histopathology. 2008;52:119–29.
Shenjere P, Fisher C, Rajab R, et al. Melanoma with rhabdomyosarcomatous differentiation: two further cases of a rare pathologic pitfall. Int J Surg Pathol. 2014;22:512–9.
Pasz-Walczak G, Jesionek-Kupnicka D, Kubiak R, et al. Rhabdomyosarcomatous (myoblastic?) phenotype of metastatic malignant melanoma. A case report. Pol J Pathol. 2002;53:97–100.
Gharpuray-Pandit D, Coyne J, Eyden B, et al. Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases. Int J Surg Pathol. 2007;15:20–5.
Gattenlohner S, Brocker EB, Muller-Hermelink HK. Malignant melanoma with metastatic rhabdomyosarcomatoid transdifferentiation. N Engl J Med. 2008;358:649–50.
Reilly DJ, Volchek M, Ting JW, et al. Rhabdomyoblastic differentiation in metastatic melanoma: making sense of a rare but complex form of mimicry. Int J Surg Pathol. 2014;22:520–4.
Govender D, Pillay P. Primary myxoid liposarcoma with rhabdomyoblastic differentiation. Arch Pathol Lab Med. 1998;122:740–2.
Shanks JH, Banerjee SS, Eyden BP. Focal rhabdomyosarcomatous differentiation in primary liposarcoma. J Clin Pathol. 1996;49:770–2.
McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213–23.
Longano A, DuGuesclin A, Mitchell C. Primary dedifferentiated liposarcoma of the lung with rhabdomyoblastic and chrondroblastic differentiation. Histopathology. 2014. doi: 10.1111/his.12410.
Okamoto S, Machinami R, Tanizawa T, et al. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation in an 8-year-old girl. Pathol Res Pract. 2010;206:191–6.
Shimada S, Ishizawa T, Ishizawa K, et al. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation. Virchows Arch. 2005;447:835–41.
Chan AC, Tsang WY, Chan GP, et al. Dedifferentiated chordoma with rhabdomyoblastic differentiation. Pathology. 2007;39:277–80.
Seethala RR, Sturgis EM, Raymond AK, et al. Postirradiation osteosarcoma of the mandible with heterologous differentiation. Arch Pathol Lab Med. 2006;130:385–8.
Adhikari LA, McCalmont TH, Folpe AL. Merkel cell carcinoma with heterologous rhabdomyoblastic differentiation: the role of immunohistochemistry for Merkel cell polyomavirus large T-antigen in confirmation. J Cutan Pathol. 2012;39:47–51.
Eusebi V, Damiani S, Pasquinelli G, et al. Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol. 2000;24:223–30.
Pettinato G, Manivel JC, d’Amore ES, et al. Melanotic neuroectodermal tumor of infancy. A reexamination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol. 1991;15:233–45.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was written by members of the International Head Neck Scientific Group (www.IHNSG.com).
Rights and permissions
About this article
Cite this article
Bishop, J.A., Thompson, L.D.R., Cardesa, A. et al. Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma. Head and Neck Pathol 9, 507–518 (2015). https://doi.org/10.1007/s12105-015-0624-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-015-0624-2